Considering the broader literature, our finding suggests that the “neuroprogressive” pathology of bipolar disorder outpaces chronological age‐related brain changes, and this has a neuroinflammatory component given the elevated GFAP levels. The gene discussed is GFAP; the disease is bipolar disorder.